Renal interstitial concentration of adenosine during endotoxin shock

European Journal of Pharmacology

Volumn 385, Issue 2-3, 1999, Pages 209-216

  Nishiyama, Akira ^a   Miura, Katsuyuki ^b   Miyatake, Akira ^a   Fujisawa, Yoshihide ^a   Yue, Wang ^a   Fukui, Toshiki ^a   Kimura, Shoji ^a   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenosine; Adenosine A1 receptor antagonist; Endotoxin shock; Lipopolysaccharide; Microdialysis; Renal hemodynamics

Indexed keywords

1 [3 (2 PHENYLPYRAZOLO[1,5 A]PYRIDIN 3 YL)ACRYLOYL]PIPERIDINE 2 ACETIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ENDOTOXEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; VASOCONSTRICTION;

EID: 0032806312     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00716-5     Document Type: Article

References (27)

1. Aki Y., Nishiyama A., Tomohiro A., Kimura S., Abe Y. Interaction between adenosine and vasoconstrictors in renal vascular beds. (abstract) Nephrology. 3(Suppl. 1):1997;S46.
2. Badr K.F., Kelley V.E., Rennke H.G., Brenner B.M. Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int. 30:1986;474-480.
3. Baranowski R.L., Westenfelder C. Estimation of renal interstitial adenosine and purine metabolites by microdialysis. Am. J. Physiol. 267:1994;F174-F182.
4. Churchill P.C., Bidani A.K. Adenosine mediates hemodynamic changes in renal failure. Med. Hypotheses. 8:1987;275-285.
5. Churchill P.C., Bidani A.K., Schwartz M.M. Renal effects of endotoxin in the male rat. Am. J. Physiol. 253:1987;F244-F250.
6. Groeneveld A.B.J., Tran D.D., Meulen J., Nauta J.J.P., Thijs L.G. Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron. 59:1991;602-610.
7. Gullichsen E. Renal perfusion and metabolism in experimental endotoxin shock. Acta Chir. Scand., Suppl. 560:1991;7-31.
8. He H., Miura K., Aki Y., Kimura S., Tamaki T., Iwao H., Abe Y. Adenosine metabolism in the renal interstitial space during ischemia and hypertonic saline infusion. (abstract) Am. J. Hypertens. 8:1995;156A.
9. Henrich W.L., Hamasaki Y., Said S.I., Campbell W.B., Cronin R.E. Dissociation of systemic and renal effects in endotoxemia: prostaglandin inhibition uncovers an important role of renal nerves. J. Clin. Invest. 69:1982;691-699.
10. Hinshaw L.B., Bradley G.M. Alterations in kidney weight produced by Escherichia coli endotoxin. Am. J. Physiol. 189:1957;329-330.
11. Hinshaw L.B., Spink W.W., Vick J.A., Mallet E., Finstad J. Effect of endotoxin on kidney function and renal hemodynamics in the dog. Am. J. Physiol. 201:1961;144-148.
12. Isakson P.C., Shofer F., Mcknight R.C., Feldhaus R.A., Raz A., Needleman P. Prostaglandins and the renin-angiotensin system in canine endotoxemia. J. Pharmacol. Exp. Ther. 200:1977;614-622.
13. Keeler R. Effects of methysergide or phenoxybenzamine on the renal and cardiovascular responses to endotoxin in rats. Circ. Shock. 8:1981;361-368.
14. 1 adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine on acute renal dysfunction induced by Escherichia coli endotoxin in rats. J. Pharm. Pharmacol. 45:1993;979-984.
15. Kusunoki T., Terai T., Akahane A., Shiokawa Y., Minoura H., Kohno Y., Yoshida K., Senoh H., Tanaka H. FK352, a novel, water-soluble, A1-selective, adenosine antagonist. (abstract) Jpn. J. Pharmacol. 67(Suppl. I):1995;318P.
16. Levy E.M., Viscoli C.M., Horwitz R.I. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 275:1996;1489-1494.
17. Miura K., Okumura M., Yukimura T., Yamamoto K. Fluorometric determination of plasma adenosine concentrations using high-performance liquid chromatography. Anal. Biochem. 196:1991;84-88.
18. Murray R.D., Churchill P.C. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists. J. Pharmacol. Exp. Ther. 232:1985;189-193.
19. Nishiyama A., Miyatake A., Aki Y., Fukui T., Kiyomoto H., Kimura S., Abe Y. Continuous monitoring of the renal interstitial adenosine concentration in conscious rats. (abstract) J. Am. Soc. Nephrol. 8:1997;351A.
20. Nishiyama A., Miyatake A., Kusudo K., Syokoji T., Yue W., Fukui T., Aki Y., Kimura S., Abe Y. Effects of halothane on renal hemodynamics and interstitial nitric oxide in rabbits. Eur. J. Pharmacol. 367:1999;299-306.
21. Nykiel F., Glaviano V.V. Adrenal catecholamines in E. coli endotoxin shock. J. Appl. Physiol. 16:1961;348-350.
22. Osswald H., Schmitz H.J., Kemper R. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischem recirculation. Pfluegers Arch. 371:1977;45-49.
23. Osswald H., Spielman W.S., Knox F.G. Mechanism of adenosine-mediated decrease in glomerular filtration rate in dogs. Circ. Res. 43:1978;465-469.
24. Pawlowska D., Granger J.P., Knox F.G. Effects of adenosine infusion into renal interstitium on renal hemodynamics. Am. J. Physiol. 252:1987;F678-F682.
25. Petrucco O., Rao P., Cavanagh D. Endotoxin shock in the dog. Am. J. Obstet. Gynecol. 114:1972;1060-1065.
26. Siragy H.M., Linden J. Sodium intake markedly alters renal interstitial fluid adenosine. Hypertension. 27:1996;404-407.
27. Spielman W.S., Thompson C.I. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am. J. Physiol. 242:1982;F423-F435.